“C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo Post Surgery and Radiation Therapy in Patients With High-Risk Cutaneous Squamous Cell Carcinoma”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s173, https://doi.org/10.25251/skin.7.supp.173.